Dr. Emilio Torres-Netto, MD, PhD, is a cornea and cataract surgeon at the ELZA Institute in Zurich. Emilio was featured in this month’s issue of
Insieme21, an association for people with trisomy 21, their parents, carers, and relatives in German-speaking Switzerland, recently featured the ELZA Institute in the 2021 edition
Accelerated CXL. For many years now, cornea specialists have used the excellent 10 minutes at 9 mW/cm² protocol to cross-link adults with keratoconus. Why? Because
Prof. Farhad Hafezi, Medical Director of the ELZA Institute, Zurich, Switzerland was the second-placed winner of the VSY Biotechnology’s Ophthalmology Star awards 2021, presented at
Prof. Farhad Hafezi was recently profiled in the Swiss newspaper, Limmattaler Zeitung, in which he discussed everything from his pioneering research into corneal cross-linking (CXL), how he has spent the last two decades improving CXL to better treat not just keratoconus, but infections of the cornea too – in a way that doesn’t require antibiotics or antifungal drugs to kill the infectious organisms.
Here’s the latest news from Expertscape: ELZA’s consultant surgeons are world leaders! Prof. Farhad Hafezi, MD, PhD, FARVO ranked in the world’s top ten –
It’s clear that there is a link between eye rubbing and keratoconus. Eye rubbing can alter the strength of the cornea, which can cause keratoconus to
We at the ELZA Institute are proud to report that our landmark paper that describes how the sub400 protocol is used to perform CXL in
An article in Ophthalmology Times Europe highlights modern keratoconus care, and features ELZA Medical Director Prof. Farhad Hafezi.
What effect does corneal cross-linking have after 10 years? This August, ELZA doctor and researcher, Emilio Torres-Netto MD was interviewed by TouchOphthalmology on a recent congress presentation he gave on 10-year cross-linking follow-up data collated from two treatment centers in Zurich, and was asked about what the research group found.
